Although several studies have explored the cytotoxic role of PAMAM-drug conjugate in cancers [21], [22], [23], [24], [25], the impact of naked PAMAM particles in breast cancer, especially HER2-positive subtype, remains unknown. Here, ERBB2 is linked to breast cancer.